Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Amendment to debt facilities

30 Sep 2009 07:00

RNS Number : 9260Z
e2v technologies PLC
30 September 2009
 



30 September 2009

e2v technologies plc

Amendment to debt facilities

e2v technologies plc, the specialist developer and manufacturer of high technology components and sub-systems, announces that it has today entered into a waiver and amendment of its existing debt facilities.

As previously announced, e2v has been working with its financial advisors to review a range of options for the most appropriate long term capital structure for the Group. As part of this review, e2v has held discussions with its debt providers and has today entered into a waiver and amendment agreement to its current facilities agreement

The waiver relates to the testing of its financial covenants under the facilities agreement, due on 30 September 2009, which will no longer take place. The amendments to the facilities agreement incur a fee, payable by e2v to the debt providers, of 75 basis points on a revised facilities amount of £150m and include an additional covenant test due on 30 November 2009. The term of the facilities agreement remains unchanged at 12 July 2011.

Although it is anticipated that the financial covenants, due to be tested on 30 September 2009, would not have been breached, the waiver and amendment agreement provides certainty and has enabled the Board to progress key terms with debt providers for the long term capital structure for the Group.

The additional covenant test, due on 30 November 2009, will include the benefit of proceeds arising from any potential equity capital raising, provided that it has been both fully underwritten and approved by shareholders by 30 November 2009. Preparations are now underway for a potential equity capital raising by the Company to meet this timetable.

e2v will release a period end trading update for the six months ended 30 September 2009 in due course.

Further enquiries:

e2v technologies plc

Keith Attwood, Chief Executive

Charles Hindson, Group Finance Director

Tel: 01245 493 493

Website: www.e2v.com

Financial Dynamics

Jon Simmons / Susanne Yule/Sophie Kernon

Tel: 020 7269 7291

NOTES FOR EDITORS

e2v 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical & science, aerospace & defence, and commercial & industrial markets.

e2v is organised into four divisions:

High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, radar systems, industrial heating, satellite communications amplifiers and digital television transmitters.
Advanced CCD and CMOS imaging sensors and cameras for applications including space, science and life science imaging, industrial process control, intra-oral and panoramic dental X-ray systems, military surveillance and automotive imaging.
Specialist Semiconductors - including logic, memory and microprocessors for high reliability microprocessor and MRAM requirements, in partnership with Freescale Semiconductor and Everspin, mission-critical avionics and defence programs requiring high reliability integrated circuits, high speed data converters and sensor data acquisition utilising mixed signal application specific devices.
A range of professional sensing products for applications including environmental safety, x-ray spectroscopy, automotive alarm and security systems, microwave radar and safety and arming devices, fire rescue and security thermal imaging.

For the year ended 31 March 2009, e2v achieved sales of £233m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. 

The Company is headquartered in the United Kingdom and has approximately 1700 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Further information is available from www.e2v.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWUUQCBUPBUAU
Date   Source Headline
26th Mar 20154:45 pmRNSHoldings in Company
19th Feb 201512:56 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Feb 20154:04 pmRNSTotal Voting Rights
30th Jan 20157:00 amRNSQuater three update
22nd Jan 20152:24 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jan 20152:55 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Dec 20141:30 pmRNSTR-1: Notification of Major Interest in Shares
14th Nov 20143:27 pmRNSTR-1: Notification of Major Interest in Shares
11th Nov 20144:00 pmRNSTR-1: Notification of Major Interest in Shares
11th Nov 20143:43 pmRNSTR-1: Notification of Major Interest in Shares
11th Nov 20143:42 pmRNSTR-1: Notification of Major Interest in Shares
10th Nov 20144:07 pmRNSDirector/PDMR Shareholding - Replacement
10th Nov 20142:52 pmRNSDirector/PDMR Shareholding
10th Nov 20147:00 amRNSHalf Yearly Results
30th Oct 20148:38 amRNSTR-1: Notification of Major Interest in Shares
30th Oct 20148:35 amRNSTR-1: Notification of Major Interest in Shares
16th Oct 20147:00 amRNSPeriod End Update
22nd Sep 20143:37 pmRNSHolding(s) in Company
17th Sep 20148:39 amRNSNotice of Interim Results Announcement
15th Sep 201410:09 amRNSHolding(s) in Company
8th Sep 20142:17 pmRNSDirector/PDMR Shareholding
5th Sep 20143:34 pmRNSHolding(s) in Company
4th Sep 20142:53 pmRNSCompletion of acquisition
2nd Sep 20144:06 pmRNSTotal Voting Rights
8th Aug 201410:21 amRNSAwards under Long Term Incentive Plan
4th Aug 20142:36 pmRNSDirector/PDMR Shareholding
4th Aug 20141:45 pmRNSHolding(s) in Company
4th Aug 20147:08 amRNSAcquisition of AnaFocus
16th Jul 20149:56 amRNSResult of AGM
16th Jul 20147:00 amRNSInterim Management Statement
1st Jul 201412:18 pmRNSHolding(s) in Company
25th Jun 20143:02 pmRNSHolding(s) in Company
16th Jun 20144:20 pmRNSNotice of AGM
16th Jun 20144:15 pmRNSHolding(s) in Company
13th Jun 20141:25 pmRNSHolding(s) in Company
23rd May 20141:56 pmRNSHolding(s) in Company
19th May 20147:00 amRNSFinal Results
15th Apr 20147:00 amRNSTrading Statement
17th Mar 20144:47 pmRNSHolding(s) in Company
13th Mar 20143:08 pmRNSAwards under Share Incentive Plan
25th Feb 20147:00 amRNSChange of Director Details
21st Feb 20142:03 pmRNSHolding(s) in Company
3rd Feb 20145:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20145:00 pmRNSTotal Voting Rights
3rd Feb 20145:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20145:00 pmRNSTransaction in Own Shares
31st Jan 201412:10 pmRNSHolding(s) in Company
31st Jan 20147:00 amRNSInterim Management Statement
28th Jan 20147:00 amRNSDirector Declaration
28th Jan 20147:00 amRNSAppointment of Chief Executive - Start Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.